← Back to INDPReportPortrait · background graphics on

SPZCOIndaptus Therapeutics, Inc. · INDPData at close 2026-08-19

Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1857044 · FYE Dec 31 · Prices AT CLOSE 2026-08-19 (USD)

Last $0.94Day +0.42%Mkt cap $125M1Y −87.3%Off 52W high −89.0%Vol (1Y) 169.4%

Price2023-08-21 → 2026-08-19

INDP close: $68 on 2023-08-21 to $1 on 2026-08-19.

Split-adj closes · 240 of 1,260 · price return

At a glance

Short interest0.1% of sh out

Days to cover1.1d

13F net flow (QoQ)−0.00%

Top-10 13F concentration100.0%

Next report (est.)2026-11-12

SI 2026-07-31 · 13F 2026-Q1

Key fundamentalsFY 2025

Earnings (TTM)-$15.4M

ROE−587.6%

FY ratios · TTM sales/earnings (USD)

Trailing returns

YTD−67.7%

1Y−87.3%

3Y−98.6%

5Y−99.6%

Since incept. (ann.)−67.9%

Total return · from 2021-08-05

Risk

Ann. volatility (1Y)169.4%

Ann. volatility (3Y)131.9%

Sharpe (1Y)−0.48

Sharpe (3Y)−0.49

Max drawdown (1Y)−87.9%

Max drawdown (3Y)−99.1%

Beta (3Y vs SPY)1.21

Daily returns, ann.

Top institutional holders13F 2026-Q1

Manager	Shares	Value	% sh out	QoQ
CITADEL ADVISORS LLC	39,018	$71,013	1.74%	new
GEODE CAPITAL MANAGEMENT, LLC	27,007	$49,152	1.20%	new
MORGAN STANLEY	2,697	$4,909	0.12%	new
Tower Research Capital LLC (TRC)	1,890	$3,440	0.08%	−40.0%
SBI Securities Co., Ltd.	17	$31	0.00%	+0.0%
CWM, LLC	2	$4	0.00%	new

Δ vs 2025-Q4

Latest reported quarterslast report 2026-08-13

Period end	Reported	EPS	EPS YoY	Revenue	Rev YoY
2026-06-30	2026-08-13	−$0.02	—	—	—
2026-03-31	2026-05-15	−$0.23	—	—	—
2025-09-30	2025-11-12	−$2.98	—	—	—
2025-06-30	2025-08-13	−$9.09	—	—	—

As-reported XBRL · next 2026-11-12 est.

Basis & disclosures